A new study published in Nature Communications has homed in on a part of the SARS-CoV-2 spike protein that seems to be shared across all known variants. The research also reveals an antibody fragment that can hypothetically block the virus from entering human cells, paving the way for future therapies to neutralize all COVID-19 variants.

i have noticed that for say an 8th gen Intel box, 6 core, it won't queue more than about 24 work units at a time despite having my queue settings maxxed out in BOINC at 10 days in both fields.

A new lethal virus known as NeoCoV has been discovered, and it may be more transmissible - with one mutation - according to a new study by Chinese scientists from Wuhan, though some experts are cautioning that further study is needed. It has not yet made the leap to humans.

Two doses of a Covid vaccine are not enough to stop you catching the Omicron variant, UK scientists have warned.
Early analysis of UK Omicron and Delta cases showed the vaccines were less effective at stopping the new variant.

However, a third booster dose significantly increased protection to around 75%.

We're back in familiar territory - growing concern about a new variant of coronavirus. The latest is the most heavily mutated version discovered so far - and it has such a long list of mutations that it was described by one scientist as "horrific", while another told me it was the worst variant they'd seen.

we should do HTVS also for NIPAH. Do you have an idea which protein to target?

Are those targets solved by AlphaFold already? How to compare Sidock to AlphaDock ?

A group of seven residents in a Belgian nursing home died after infection with a new variant, all of whom were fully vaccinated according to virologists on the scene. Though the vaccine used in these residents was not made public, it was likely either AstraZeneca or an mRNA vaccine such as Pfizer and Moderna, among those most frequently used in the country.

The new variant, B.1.621, has yet to receive a greek letter designation from the World Health Organization. The variant already accounts for around 2% of coronavirus infections in the United States, and as much as 10% in Miami, according to Carlos Migoya, CEO of Jackson Health System. The variant can be traced back to identification in samples from Colombia in March 2021 and according to the GISAID coronavirus database, the variant has been identified in as many as 28 countries, but potentially more.

Despite not having the official label of Variant of Interest or Concern, it should be noted that B.1.621 has certain characteristics that suggest it may be worth watching, as it could become a variant of interest or concern in the near future. Here we analyze those mutations and summarize what we know about their likely effects on transmissibility, virulence, vaccine evasion, and pathogenesis.

Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, reveals study

<app_config>
<report_results_immediately/>
</app_config>